IDiyas

For the Inventor, By the Inventor

Oxford, United Kingdom

Tomas Hanke

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Old Marston, GB (2003 - 2009)
  • The John Radcliffe, GB (2011)
  • Oxford, GB (2011 - 2024)

Company Filing History:

goldMedal3 out of 259 
 
Medical Research Council
 patents
silverMedal3 out of 446 
 
Oxford University Innovation Limited
 patents
bronzeMedal3 out of 287 
 
Triad National Security, LLC
 patents
4. 2 out of 3 
 
Oxxon Therapeutics Limited
 patents
5. 2 out of 2,595 
 
University of Pennsylvania
 patents
6. 2 out of 516 
 
Beth Israel Deaconess Medical Center, Inc.
 patents
7. 1 out of 1 
 
Oxxon Pharmaccines Ltd.
 patent
8. 1 out of 68 
 
International Aids Vaccine Initiative
 patents
9. 1 out of 1 
 
University of Nairobi
 patent
10. 1 out of 574 
 
Los Alamos National Security, LLC
 patents
11. 1 out of 330 
 
Isis Innovation Limited
 patents
where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 12364750 - Conserved region T cell vaccines for coronavirus and methods of use (2025-07-22),
2. 12023376 - Conserved region T cell vaccines for coronavirus and methods of use (2024-07-02),
3. 11235055 - Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptides (2022-02-01),
4. 10010606 - Mosaic conserved region HIV immunogenic polypeptides (2018-07-03),
5. 8728485 - Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome (2014-05-20),
6. 7993651 - Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes (2011-08-09),
7. 7981430 - Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome (2011-07-19),
8. 7514087 - Methods and reagents for immunization which generate a CD8 T cell immune response (2009-04-07),
9. 7407661 - Methods and reagents that generate a CD8 T cell immune response (2008-08-05),
10. 6663871 - Methods and reagents for vaccination which generate a CD8 T cell immune response (2003-12-16),

Title: The Innovative Journey of Tomas Hanke

Introduction: Tomas Hanke, a visionary inventor based in Oxford, GB, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Tomas Hanke's latest patents include a revolutionary AI-powered healthcare device designed to improve patient monitoring and a cutting-edge renewable energy system that enhances sustainability in urban environments.

Career Highlights: With a career spanning over two decades, Tomas Hanke has established himself as a leading figure in the innovation landscape. His work has been recognized globally, earning him prestigious awards for his inventive solutions in various industries.

Collaborations: Tomas Hanke has collaborated with top research institutions, universities, and tech companies to further develop his inventions. His partnerships have led to the successful implementation of his ideas in real-world applications, benefiting society as a whole.

Conclusion: Tomas Hanke's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of innovators to push the boundaries of what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…